End Stage Kidney Disease
53
11
15
26
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
2 terminated out of 53 trials
92.9%
+6.3% vs benchmark
15%
8 trials in Phase 3/4
19%
5 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 26 completed trials
Clinical Trials (53)
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Virtual Reality in End Stage Kidney Disease
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Pain Reduction Using NEurostimulation Study
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease
Virtual Reality in Hemodialysis to Improve Psychological Well-being
An Observational Study of Patients With Chronic Kidney Disease
Immunological Tolerance in Patients With Mismatched Kidney Transplants
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Symptom Monitoring in Hemodialysis
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
SelfWrap-Assisted Arteriovenous Fistulas
Duke APOL1 Research Biorepository